However, caveats considered, the authors write, If true, our data anticipate increasing numbers of NAION cases related to this class of drugs. They believe that their research is the first to find a link between NAION risk and semaglutide
While clinical studies have shown weight loss effects for semaglutide, the active ingredient in the FDA-approved medications Ozempic and Wegovy (86.4% of study participants given the drug lost 5% or more of their body weight), no equivalent research exists for berberine
GLP-1 nutrition specialists typically earn more than general clinical dietitians due to specialized expertise and high demand
Eur J Pharmacol 296 : 129136 Parnetti L, Gaiti A, Mecocci P, Cadini D, Senin U
The 7.2 mg dose is currently given as three 2.4 mg pens, with all three doses taken together once weekly, until a single 7.2 mg pen becomes available